Exact Mass: 1176.6291216

Exact Mass Matches: 1176.6291216

Found 26 metabolites which its exact mass value is equals to given mass value 1176.6291216, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Asterlingulatoside D

3-{[5-({3,5-dihydroxy-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl}oxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl 5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid

C57H92O25 (1176.5927382)


Asterlingulatoside D is a constituent of Codonopsis lanceolata (todok) Constituent of Codonopsis lanceolata (todok).

   

IV2Fuc-nLc4Cer

N-[(2S,3R)-1-{[(2R,3R,4R,5S,6R)-5-{[(2S,3R,4S,5S,6R)-4-{[(2S,3R,4R,5S,6R)-5-{[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]ethanimidic acid

C52H92N2O27 (1176.5887162)


IV2Fuc-nLc4Cer is classified as a member of the Glycosyl-N-acylsphingosines. Glycosyl-N-acylsphingosines are compounds containing a sphingosine linked to a simple glucosyl moiety. IV2Fuc-nLc4Cer is considered to be slightly soluble (in water) and acidic

   

Pseudoproto Pb

Pseudoproto Pb

C57H92O25 (1176.5927382)


   

Lipopeptin A

Lipopeptin A

C54H84N10O19 (1176.5913914)


   

Capilliposide B

Capilliposide B

C58H96O24 (1176.6291216)


A triterpenoid saponin that consists of anagalligenin A substituted by a caproyl group at position 22 and a beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->2)]-alpha-L-arabinopyranosyl moiety at position 3 via a glycosidic linkage. It is isolated from the whole plants of Lysimachia capillipes and has been shown to exhibit potent cytotoxicity against human A-2780 cells.

   

3beta-[(O-alpha-L-arabinopyranosyl-(1->4)-O-beta-D-xylopyranosyl-(1->2)-O-[beta-D-xylopyranosyl-(1->4)]-beta-D-glucopyranosyl)oxy]-2alpha-hydroxyolean-12-en-28-oic acid alpha-L-rhamnopyranosyl ester|stryphnoside B

3beta-[(O-alpha-L-arabinopyranosyl-(1->4)-O-beta-D-xylopyranosyl-(1->2)-O-[beta-D-xylopyranosyl-(1->4)]-beta-D-glucopyranosyl)oxy]-2alpha-hydroxyolean-12-en-28-oic acid alpha-L-rhamnopyranosyl ester|stryphnoside B

C57H92O25 (1176.5927382)


   

C57H92O25

C57H92O25 (1176.5927382)


   

metaplexigenin 3-O-beta-D-glucopyranosyl-(1->4)-b-(6-deoxy-3-O-methyl)-D-allopyranosyl-(1->4)-beta-D-oleandropyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-cymaropyranose|verticilloside D

metaplexigenin 3-O-beta-D-glucopyranosyl-(1->4)-b-(6-deoxy-3-O-methyl)-D-allopyranosyl-(1->4)-beta-D-oleandropyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-cymaropyranose|verticilloside D

C57H92O25 (1176.5927382)


   

stachyssaponin VIII

stachyssaponin VIII

C57H92O25 (1176.5927382)


   

Araliasaponin I

Araliasaponin I

C57H92O25 (1176.5927382)


   

Ciltoprazin

3-{[5-({3,5-dihydroxy-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl}oxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl 5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate

C57H92O25 (1176.5927382)


   

PIM2 35:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp)-(1-heptadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C56H105O23P (1176.678391)


   

N-[(2S,3R,4R,5S,6R)-2-[(2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-6-[(Z,2S,3R)-2-acetamido-3-hydroxyoctadec-4-enoxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-5-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

N-[(2S,3R,4R,5S,6R)-2-[(2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-6-[(Z,2S,3R)-2-acetamido-3-hydroxyoctadec-4-enoxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-5-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

C52H92N2O27 (1176.5887162)


   

1-O-(1-O-palmitoyl-2-O-tuberculostearoylglycero-3-phosphono)-2,5-di-O-D-mannopyranosyl-1-alpha-D-myo-inositol

1-O-(1-O-palmitoyl-2-O-tuberculostearoylglycero-3-phosphono)-2,5-di-O-D-mannopyranosyl-1-alpha-D-myo-inositol

C56H105O23P (1176.678391)


   

IV2Fuc-nLc4Cer

IV2Fuc-nLc4Cer

C52H92N2O27 (1176.5887162)


   

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C63H102O16P2 (1176.6642752)


   

Ac2PIM2 16:0_18:0(methyl)

Ac2PIM2 16:0_18:0(methyl)

C56H105O23P (1176.678391)


   

Ac2PIM2 18:0(methyl)_16:0

Ac2PIM2 18:0(methyl)_16:0

C56H105O23P (1176.678391)


   

Ac2PIM2 18:0_17:0

Ac2PIM2 18:0_17:0

C56H105O23P (1176.678391)


   

Ac2PIM2 17:0_18:0

Ac2PIM2 17:0_18:0

C56H105O23P (1176.678391)


   

Ac2PIM2 15:0_20:0

Ac2PIM2 15:0_20:0

C56H105O23P (1176.678391)


   

Ac2PIM2 16:0_19:0

Ac2PIM2 16:0_19:0

C56H105O23P (1176.678391)


   

Ac2PIM2 20:0_15:0

Ac2PIM2 20:0_15:0

C56H105O23P (1176.678391)


   

Ac2PIM2 19:0_16:0

Ac2PIM2 19:0_16:0

C56H105O23P (1176.678391)


   

MLCL 54:11

MLCL 54:11

C63H102O16P2 (1176.6642752)


   

PIM2 36:7

PIM2 36:7

C57H93O23P (1176.5844958)